# Nuvalent, Inc. (NUVL) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Nuvalent, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/NUVL/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-073317 (https://www.sec.gov/Archives/edgar/data/1861560/000119312526073317/nuvl-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/NUVL/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-028328 (https://www.sec.gov/Archives/edgar/data/1861560/000095017025028328/nuvl-20241231.htm)
- [FY 2023 MD&A](/company/NUVL/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-020607 (https://www.sec.gov/Archives/edgar/data/1861560/000095017024020607/nuvl-20231231.htm)
- [FY 2022 MD&A](/company/NUVL/mda/fy2022/): filed 2023-03-16; accession 0000950170-23-008284 (https://www.sec.gov/Archives/edgar/data/1861560/000095017023008284/nuvl-20221231.htm)
- [FY 2021 MD&A](/company/NUVL/mda/fy2021/): filed 2022-03-29; accession 0001193125-22-087401 (https://www.sec.gov/Archives/edgar/data/1861560/000119312522087401/d319667d10k.htm)

Back to /company/NUVL/